Global Pharmaceuticals Industry Almanac - Market Summary, Competitive Analysis and Forecast to 2025

Global Pharmaceuticals Industry Almanac - Market Summary, Competitive Analysis and Forecast to 2025

Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
- All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2020 annual average exchange rates.
- Forecast figures presented in this report are calculated using crisis scenarios for the market. The length of the pandemic and restrictions introduced by various countries are still difficult to predict. Many governments had introduced the national lockdowns and temporarily banned sales of products that are deemed "non-essential". As the length of the pandemic and its impact on this market is not certain, the data used in this report has been modeled taking forecast impacts on national economics into consideration.
- The global pharmaceuticals market had total revenues of $1,112.6bn in 2020, representing a compound annual growth rate (CAGR) of 5.6% between 2016 and 2020.
- Given the strong global demand for vaccines to protect citizens and control the spread of COVID-19, it is likely that pharmaceutical companies offering safe and effective therapeutic solutions will generate significant revenues, contributing to market growth.
- The promotion of generic drugs has become increasingly prevalent globally as many governments seek to generate savings amid rising pharmaceutical prices, and this presents a barrier to growth in the market.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

Reasons to Buy

- What was the size of the global pharmaceuticals market by value in 2020?
- What will be the size of the global pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the global pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the global pharmaceuticals market?
Table of Contents
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Competitive Landscape
2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions
3 Global Pharmaceuticals
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
4 Pharmaceuticals in Asia-Pacific
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
5 Pharmaceuticals in Europe
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators
6 Pharmaceuticals in France
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators
7 Pharmaceuticals in Germany
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
7.6. Macroeconomic Indicators
8 Pharmaceuticals in Australia
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
8.6. Macroeconomic Indicators
9 Pharmaceuticals in Brazil
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
9.6. Macroeconomic Indicators
10 Pharmaceuticals in Canada
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
10.6. Macroeconomic Indicators
11 Pharmaceuticals in China
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
11.6. Macroeconomic Indicators
12 Pharmaceuticals in India
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis
12.6. Macroeconomic Indicators
13 Pharmaceuticals in Indonesia
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis
13.6. Macroeconomic Indicators
14 Pharmaceuticals in Italy
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis
14.6. Macroeconomic Indicators
15 Pharmaceuticals in Japan
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis
15.6. Macroeconomic Indicators
16 Pharmaceuticals in Mexico
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis
16.6. Macroeconomic Indicators
17 Pharmaceuticals in The Netherlands
17.1. Market Overview
17.2. Market Data
17.3. Market Segmentation
17.4. Market outlook
17.5. Five forces analysis
17.6. Macroeconomic Indicators
18 Pharmaceuticals in North America
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis
19 Pharmaceuticals in Russia
19.1. Market Overview
19.2. Market Data
19.3. Market Segmentation
19.4. Market outlook
19.5. Five forces analysis
19.6. Macroeconomic Indicators
20 Pharmaceuticals in Scandinavia
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis
21 Pharmaceuticals in Singapore
21.1. Market Overview
21.2. Market Data
21.3. Market Segmentation
21.4. Market outlook
21.5. Five forces analysis
21.6. Macroeconomic Indicators
22 Pharmaceuticals in South Africa
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis
22.6. Macroeconomic Indicators
23 Pharmaceuticals in South Korea
23.1. Market Overview
23.2. Market Data
23.3. Market Segmentation
23.4. Market outlook
23.5. Five forces analysis
23.6. Macroeconomic Indicators
24 Pharmaceuticals in Spain
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis
24.6. Macroeconomic Indicators
25 Pharmaceuticals in Turkey
25.1. Market Overview
25.2. Market Data
25.3. Market Segmentation
25.4. Market outlook
25.5. Five forces analysis
25.6. Macroeconomic Indicators
26 Pharmaceuticals in The United Kingdom
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis
26.6. Macroeconomic Indicators
27 Pharmaceuticals in The United States
27.1. Market Overview
27.2. Market Data
27.3. Market Segmentation
27.4. Market outlook
27.5. Five forces analysis
27.6. Macroeconomic Indicators
27.7. Country data
28 Company Profiles
28.1. Bayer AG
28.2. Yangtze River Pharmaceutical Group
28.3. Laboratoires Pierre Fabre SA
28.4. Les Laboratoires Servier
28.5. Boehringer Ingelheim GmbH
28.6. AstraZeneca PLC
28.7. Ache Laboratorios Farmaceuticos SA
28.8. Hypera SA
28.9. EMS Sigma Pharma
28.10. Apotex, Inc.
28.11. Merck & Co., Inc.
28.12. Shanghai Pharmaceuticals Holding Co Ltd
28.13. Yunnan Baiyao Group Co Ltd
28.14. Guangzhou Pharmaceutical Holdings Ltd
28.15. Sun Pharmaceutical Industries Ltd
28.16. Lupin Ltd
28.17. Aurobindo Pharma Ltd
28.18. Dr. Reddys Laboratories Limited
28.19. PT Kimia Farma Tbk
28.20. Novartis AG
28.21. A Menarini Industrie Farmaceutiche Riunite Srl
28.22. Chiesi Farmaceutici SpA
28.23. Recordati S.p.A.
28.24. Daiichi Sankyo Co Ltd
28.25. Mitsubishi Tanabe Pharma Corporation
28.26. Takeda Pharmaceutical Company Limited
28.27. Genomma Lab Internacional SAB de CV
28.28. Johnson & Johnson
28.29. Merck & Co., Inc.
28.30. F. Hoffmann-La Roche Ltd
28.31. Astellas Pharma Inc.
28.32. Adcock Ingram Holdings Ltd
28.33. Aspen Pharmacare Holdings Ltd
28.34. Chong Kun Dang Pharmaceutical Corp
28.35. Daewoong Pharmaceutical Co Ltd
28.36. Hanmi Pharmaceuticals Co Ltd
28.37. Almirall S.A.
28.38. Laboratorios Farmaceuticos ROVI, S.A.
28.39. Sanofi SA
28.40. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
28.41. GlaxoSmithKline Plc
28.42. Pfizer Inc.
29 Appendix
29.1. Methodology
29.2. About MarketLine

List Of Tables

List of Tables
Table 1: Global pharmaceuticals market value: $ billion, 2016-20
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: Global pharmaceuticals market share: % share, by value, 2020
Table 4: Global pharmaceuticals market value forecast: $ billion, 2020-25
Table 5: Global size of population (million), 2016-20
Table 6: Global gdp (constant 2005 prices, $ billion), 2016-20
Table 7: Global gdp (current prices, $ billion), 2016-20
Table 8: Global inflation, 2016-20
Table 9: Global consumer price index (absolute), 2016-20
Table 10: Global exchange rate, 2016-20
Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2016-20
Table 12: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2020
Table 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2020
Table 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2020-25
Table 15: Europe pharmaceuticals market value: $ billion, 2016-20
Table 16: Europe pharmaceuticals market geography segmentation: $ billion, 2020
Table 17: Europe pharmaceuticals market share: % share, by value, 2020
Table 18: Europe pharmaceuticals market value forecast: $ billion, 2020-25
Table 19: Europe size of population (million), 2016-20
Table 20: Europe gdp (constant 2005 prices, $ billion), 2016-20
Table 21: Europe gdp (current prices, $ billion), 2016-20
Table 22: Europe inflation, 2016-20
Table 23: Europe consumer price index (absolute), 2016-20
Table 24: Europe exchange rate, 2016-20
Table 25: France pharmaceuticals market value: $ billion, 2016-20
Table 26: France pharmaceuticals market geography segmentation: $ billion, 2020
Table 27: France pharmaceuticals market share: % share, by value, 2020
Table 28: France pharmaceuticals market value forecast: $ billion, 2020-25
Table 29: France size of population (million), 2016-20
Table 30: France gdp (constant 2005 prices, $ billion), 2016-20
Table 31: France gdp (current prices, $ billion), 2016-20
Table 32: France inflation, 2016-20
Table 33: France consumer price index (absolute), 2016-20
Table 34: France exchange rate, 2016-20
Table 35: Germany pharmaceuticals market value: $ billion, 2016-20
Table 36: Germany pharmaceuticals market geography segmentation: $ billion, 2020
Table 37: Germany pharmaceuticals market share: % share, by value, 2020
Table 38: Germany pharmaceuticals market value forecast: $ billion, 2020-25
Table 39: Germany size of population (million), 2016-20
Table 40: Germany gdp (constant 2005 prices, $ billion), 2016-20
Table 41: Germany gdp (current prices, $ billion), 2016-20
Table 42: Germany inflation, 2016-20
Table 43: Germany consumer price index (absolute), 2016-20
Table 44: Germany exchange rate, 2016-20
Table 45: Australia pharmaceuticals market value: $ billion, 2016-20
Table 46: Australia pharmaceuticals market geography segmentation: $ billion, 2020
Table 47: Australia pharmaceuticals market share: % share, by value, 2020
Table 48: Australia pharmaceuticals market value forecast: $ billion, 2020-25
Table 49: Australia size of population (million), 2016-20
Table 50: Australia gdp (constant 2005 prices, $ billion), 2016-20
Table 51: Australia gdp (current prices, $ billion), 2016-20
Table 52: Australia inflation, 2016-20
Table 53: Australia consumer price index (absolute), 2016-20
Table 54: Australia exchange rate, 2016-20
Table 55: Brazil pharmaceuticals market value: $ billion, 2016-20
Table 56: Brazil pharmaceuticals market geography segmentation: $ billion, 2020
Table 57: Brazil pharmaceuticals market share: % share, by value, 2020
Table 58: Brazil pharmaceuticals market value forecast: $ billion, 2020-25
Table 59: Brazil size of population (million), 2016-20
Table 60: Brazil gdp (constant 2005 prices, $ billion), 2016-20
Table 61: Brazil gdp (current prices, $ billion), 2016-20
Table 62: Brazil inflation, 2016-20
Table 63: Brazil consumer price index (absolute), 2016-20
Table 64: Brazil exchange rate, 2016-20
Table 65: Canada pharmaceuticals market value: $ billion, 2016-20
Table 66: Canada pharmaceuticals market geography segmentation: $ billion, 2020
Table 67: Canada pharmaceuticals market share: % share, by value, 2020
Table 68: Canada pharmaceuticals market value forecast: $ billion, 2020-25
Table 69: Canada size of population (million), 2016-20
Table 70: Canada gdp (constant 2005 prices, $ billion), 2016-20
Table 71: Canada gdp (current prices, $ billion), 2016-20
Table 72: Canada inflation, 2016-20

List Of Figures

List of Figures
Figure 1: Global pharmaceuticals market value: $ billion, 2016-20
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: Global pharmaceuticals market share: % share, by value, 2020
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the global pharmaceuticals market, 2020
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2020
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2020
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2020
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2020
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2020
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2016-20
Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2020
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2020-25
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2020
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2020
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2020
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2020
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2020
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2020
Figure 21: Europe pharmaceuticals market value: $ billion, 2016-20
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 23: Europe pharmaceuticals market share: % share, by value, 2020
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2020-25
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2020
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2020
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2020
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2020
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2020
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2020
Figure 31: France pharmaceuticals market value: $ billion, 2016-20
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 33: France pharmaceuticals market share: % share, by value, 2020
Figure 34: France pharmaceuticals market value forecast: $ billion, 2020-25
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2020
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2020
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2020
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2020
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2020
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2020
Figure 41: Germany pharmaceuticals market value: $ billion, 2016-20
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 43: Germany pharmaceuticals market share: % share, by value, 2020
Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2020-25
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2020
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2020
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2020
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2020
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2020
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2020
Figure 51: Australia pharmaceuticals market value: $ billion, 2016-20
Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 53: Australia pharmaceuticals market share: % share, by value, 2020
Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2020-25
Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2020
Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2020
Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2020
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2020
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2020
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2020
Figure 61: Brazil pharmaceuticals market value: $ billion, 2016-20

Global Vaccine Adjuvants Market 2022 - Industry Briefing

The global vaccine adjuvants market was valued at USD 1,175 million in 2021 to USD 2,176 million by 2028, progressing at a CAGR of 9.2% from 2022 to 2028, according.This

USD 800 View Report

Global Drug Plastic Bottle Market 2022 - Industry Briefing

The global drug plastic bottle market is projected to rise by USD 2 billion by 2028. It is anticipated to expand at a CAGR of 3.8 percent during the forecast

USD 600 View Report

Global Pharmaceuticals Packaging Market Research Report 2021-2025

Pharmaceutical Packaging is the packages used for medicine. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market.

USD 3200 View Report

Global Pharmaceuticals and Food Anti-Counterfeiting Technologies Market Research Report 2021-2025

Deceptive representation of an original pharmaceutical and food product is referred to as counterfeiting. High growth of cheap and low-quality counterfeit products especially pertaining to the pharmaceutical and food industries

USD 3200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available